CPAP treatment supported by telemedicine does not improve blood pressure in high cardiovascular risk OSA patients: A randomized, controlled trial

Sleep

Volumn 37, Issue 11, 2014, Pages 1863-1870B

  Mendelson, Monique ^a,b,c   Vivodtzev, Isabelle ^a,b,c   Tamisier, Renaud ^a,b,c   Laplaud, David ^d   Dias Domingos, Sonia ^a,b,c   Baguet, Jean Philippe ^c   Moreau, Laurent ^e   Koltes, Christian ^f   Chavez, Léonidas ^g   De Lamberterie, Gilles ^g   Herengt, Frédéric ^h   Levy, Patrick ^a,b,c   Flore, Patrice ^a,b,c   Pépin, Jean Louis ^a,b,c  

^a UNIV GRENOBLE ALPES   (France)

^b University Grenoble Alpes   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d IP Santé Domicile   (France)

^e Polyclinique de Gentilly   (France)

^f Service de Pneumologie   (France)

^g Cabinet Marcel Benoit   (France)

^h Domaine Chamonix   (France)

Author keywords

Blood pressure; Cardiovascular risk; Obstructive sleep apnea; Telemedicine

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HOME MONITORING; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MOBILE APPLICATION; MOBILE PHONE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; POSITIVE END EXPIRATORY PRESSURE; POSITIVE END EXPIRATORY PRESSURE VENTILATOR; PRIMARY PREVENTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SECONDARY PREVENTION; SELF EXAMINATION; SEX DIFFERENCE; SLEEP DISORDERED BREATHING; STANDARD; SYSTOLIC BLOOD PRESSURE; TELEMEDICINE; BLOOD PRESSURE; CLINICAL TRIAL; COMPLICATION; DIET; FRANCE; KINESIOTHERAPY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK; SLEEP APNEA, OBSTRUCTIVE; SLEEP STAGE;

BLOOD PRESSURE; CELL PHONES; CONTINUOUS POSITIVE AIRWAY PRESSURE; DIET; EXERCISE THERAPY; FEMALE; FRANCE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; QUALITY OF LIFE; RISK; SLEEP APNEA, OBSTRUCTIVE; SLEEP STAGES; TELEMEDICINE;

EID: 84908419047     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.4186     Document Type: Article

References (41)

1. Douglas NJ, Polo O. Pathogenesis of obstructive sleep apnoea/hypopnoea syndrome. Lancet 1994; 344: 653-5.
2. Jaffe LM, Kjekshus J, Gottlieb SS. Importance and management of chronic sleep apnoea in cardiology. Eur Heart J 2013; 34: 809-15.
3. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34: 2159-219.
4. Pepin JL, Tamisier R, Levy P. Obstructive sleep apnoea and metabolic syndrome: put CPAP efficacy in a more realistic perspective. Thorax 2012; 67: 1025-7.
5. Brooks D, Horner RL, Kozar LF, Render-Teixeira CL, Phillipson EA. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest.1997; 99: 106-9.
6. Tamisier R, Pépin JL, Rémy J, et al. 14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans. Eur Respir J 2011; 37: 119-28.
7. Fletcher EC. The relationship between systemic hypertension and obstructive sleep apnea: facts and theory. Am J Med 1995; 98: 118-28.
8. Marin JM, Agusti A, Villar I, et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA 2012; 307: 2169-76.
9. McDaid C, Duree KH, Griffin SC, et al. A systematic review of continuous positive airway pressure for obstructive sleep apnoea-hypopnoea syndrome. Sleep Med Rev 2009; 13: 427-36.
10. Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 2007; 50: 417-23.
11. Haentjens P, Van Meerhaeghe A, Moscariello A, et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 2007; 167: 757-64.
12. Barbé F, Durán-Cantolla J, Capote F, et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 2010; 181: 718-26.
13. Pépin JL, Tamisier R, Barone-Rochette G, Launois SH, Lévy P, Baguet JP. Comparison of continuous positive airway pressure and valsartan in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 2010; 182: 954-60.
14. Barbe F, Duran-Cantolla J, Sanchez-de-la-Torre M, et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA 2012; 307: 2161-8.
15. Fox N, Hirsch-Allen AJ, Goodfellow E, et al. The impact of a telemedicine monitoring system on positive airway pressure adherence in patients with obstructive sleep apnea: a randomized controlled trial. Sleep 2012; 35: 477-81.
16. Sparrow D, Aloia M, Demolles DA, Gottlieb DJ. A telemedicine intervention to improve adherence to continuous positive airway pressure: a randomised controlled trial. Thorax 2010; 65: 1061-6.
17. Agarwal R, Bills JE, Hecht TJ, Light RP. Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis. Hypertension 2011; 57: 29-38.
18. McManus RJ, Mant J, Bray EP, et al. Telemonitoring and self-management in the control of hypertension (tasminh2): a randomised controlled trial. Lancet 2010; 376: 163-72.
19. Logan AG, McIsaac WJ, Tisler A, et al. Mobile phone-based remote patient monitoring system for management of hypertension in diabetic patients. Am J Hypertens 2007; 20: 942-8.
20. Conroy RM, Pyo K, Backer GD, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the score project. Science 2003: 987-1003.
21. Mancia G, De Backer G, Dominiczak A, et al. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-87.
22. NICE. National Collaborating Centre for Chronic Conditions. Type 2 diabetes: national clinical guideline for management in primary and secondary care (update). London: Royal College of Physicians, 2008, updated May 2009.
23. Williams B, Poulter NR, Brown MJ, et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004; 18: 139-85.
24. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991; 14: 540-5
25. Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom Res 1993; 37: 147-53
26. Sadoul P. Assessment of functional respiratory deficit. Bulletin européen de physiopathologie respiratoire 1983; 19: 3-6.
27. Mignault D, St-Onge M, Karelis AD, Allison DB, Rabasa-Lhoret R. Evaluation of the portable healthwear armband: a device to measure total daily energy expenditure in free-living type 2 diabetic individuals. Diabetes Care 2005; 28: 225-7.
28. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the consort statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008; 148: 295-309.
29. Dimsdale JE, Loredo JS, Profant J. Effect of continuous positive airway pressure on blood pressure: a placebo trial. Hypertension 2000; 35: 144-7.
30. Kohler M, Pepperell JC, Casadei B, et al. CPAP and measures of cardiovascular risk in males with OSAS. Eur Respir J 2008; 32: 1488-96.
31. Monasterio C, Vidal S, Duran J, et al. Effectiveness of continuous positive airway pressure in mild sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001; 164: 939-43.
32. Barbe F, Mayoralas LR, Duran J, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. A randomized, controlled trial. Ann Intern Med 2001; 134: 1015-23.
33. Robinson GV, Smith DM, Langford BA, Davies RJ, Stradling JR. Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J 2006; 27: 1229-35.
34. Taylor Y, Eliasson A, Andrada T, Kristo D, Howard R. The role of telemedicine in CPAP compliance for patients with obstructive sleep apnea syndrome. Sleep Breath 2006; 10: 132-8.
35. Smith CE, Dauz ER, Clements F, et al. Telehealth services to improve nonadherence: a placebo-controlled study. Telemed J E Health 2006; 12: 289-96.
36. Craig SE, Kohler M, Nicoll D, et al. Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the mosaic randomised controlled trial. Thorax 2012; 67: 1090-6.
37. Montserrat JM, Ferrer M, Hernandez L, et al. Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: a randomized controlled study with an optimized placebo. Am J Respir Crit Care Med 2001; 164: 608-13.
38. West SD, Kohler M, Nicoll DJ, Stradling JR. The effect of continuous positive airway pressure treatment on physical activity in patients with obstructive sleep apnoea: a randomised controlled trial. Sleep Med 2009; 10: 1056-8.
39. Mendelson M, Tamisier R, Laplaud D, et al. Low physical activity is a determinant for elevated blood pressure in high cardiovascular risk obstructive sleep apnea. Respir Care 2013 Nov 26. [Epub ahead of print].
40. Hood MM, Corsica J, Cvengros J, Wyatt J. Impact of a brief dietary self-monitoring intervention on weight change and CPAP adherence in patients with obstructive sleep apnea. J Psychosom Res 2013; 74: 170-4.
41. Kline CE, Crowley EP, Ewing GB, et al. The effect of exercise training on obstructive sleep apnea and sleep quality: a randomized controlled trial. Sleep 2011; 34: 1631-40.